Alan G. Zimmermann

2.5k total citations · 1 hit paper
40 papers, 1.9k citations indexed

About

Alan G. Zimmermann is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Molecular Biology. According to data from OpenAlex, Alan G. Zimmermann has authored 40 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Endocrinology, Diabetes and Metabolism, 13 papers in Genetics and 8 papers in Molecular Biology. Recurrent topics in Alan G. Zimmermann's work include Growth Hormone and Insulin-like Growth Factors (16 papers), Diabetes Treatment and Management (9 papers) and Childhood Cancer Survivors' Quality of Life (6 papers). Alan G. Zimmermann is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (16 papers), Diabetes Treatment and Management (9 papers) and Childhood Cancer Survivors' Quality of Life (6 papers). Alan G. Zimmermann collaborates with scholars based in United States, Germany and Canada. Alan G. Zimmermann's co-authors include Fady T. Botros, Katherine R. Tuttle, Brian Rayner, Mark Lakshmanan, Robert S. Busch, Christopher J. Child, Werner Blum, V. Pechtner, Jui‐Hung Sun and Francesco Giorgino and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Diabetes Care and Diabetes.

In The Last Decade

Alan G. Zimmermann

38 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7): a multicentre, open-label, randomised trial

2018 460 citations Alan G. Zimmermann et al. profile →

Peers

Countries citing papers authored by Alan G. Zimmermann

Since Specialization

Citations

This map shows the geographic impact of Alan G. Zimmermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan G. Zimmermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan G. Zimmermann more than expected).

Fields of papers citing papers by Alan G. Zimmermann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan G. Zimmermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan G. Zimmermann. The network helps show where Alan G. Zimmermann may publish in the future.

Co-authorship network of co-authors of Alan G. Zimmermann

This figure shows the co-authorship network connecting the top 25 collaborators of Alan G. Zimmermann. A scholar is included among the top collaborators of Alan G. Zimmermann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan G. Zimmermann. Alan G. Zimmermann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Screening a large pediatric cohort with GH deficiency for mutations in genes regulating pituitary development and GH secretion: Frequencies, phenotypes and growth outcomes 2018 ·EBioMedicine ·Werner Blum, Jürgen Klammt, Serge Amselem, (unknown), Marie Legendre, Marie‐Laure Sobrier, (unknown), Christopher J. Child, Christine Jones, Alan G. Zimmermann, Charmian A. Quigley, Gordon B. Cutler, Cheri Deal, Jan Lebl, Ron G. Rosenfeld, John S. Parks, Roland Pfäffle	22
2	Safety Outcomes and Near-Adult Height Gain of Growth Hormone-Treated Children with SHOX Deficiency: Data from an Observational Study and a Clinical Trial 2016 ·Hormone Research in Paediatrics ·Imane Benabbad, Myriam Rosilio, Christopher J. Child, Jean‐Claude Carel, Judith L. Ross, Cheri Deal, Stenvert L. S. Drop, Alan G. Zimmermann, Nan Jia, Charmian A. Quigley, Werner Blum	26
3	Development of additional pituitary hormone deficiencies in pediatric patients originally diagnosed with isolated growth hormone deficiency due to organic causes 2016 ·European Journal of Endocrinology ·Christopher J. Child, Werner Blum, Cheri Deal, Alan G. Zimmermann, Charmian A. Quigley, Stenvert L. S. Drop, Gordon B. Cutler, Ron G. Rosenfeld	12
4	Assessment of Primary Cancer Incidence in Growth Hormone-Treated Children: Comparison of a Multinational Prospective Observational Study with Population Databases 2016 ·Hormone Research in Paediatrics ·Christopher J. Child, Alan G. Zimmermann, Nan Jia, Leslie L. Robison, Jürgen Brämswig, Werner Blum	12
5	Radiological Features in Patients with Short Stature Homeobox-Containing <b><i>(SHOX) </i></b>Gene<b> </b>Deficiency and Turner Syndrome before and after 2 Years of GH Treatment 2015 ·Hormone Research in Paediatrics ·Christopher J. Child, G. Kalifa, Christine Jones, Judith L. Ross, Gudrun Rappold, Charmian A. Quigley, Alan G. Zimmermann, (unknown), Gordon B. Cutler, Werner Blum	17
6	Incidence of primary cancers and intracranial tumour recurrences in GH-treated and untreated adult hypopituitary patients: analyses from the Hypopituitary Control and Complications Study 2015 ·European Journal of Endocrinology ·Christopher J. Child, (unknown), Alan G. Zimmermann, Whitney W. Woodmansee, Eva Marie Erfurth, Leslie L. Robison	45
7	Efficacy and Safety of Once-Weekly Dulaglutide Versus Insulin Glargine in Patients With Type 2 Diabetes on Metformin and Glimepiride (AWARD-2) 2015 ·Diabetes Care ·Francesco Giorgino, Marian Benroubi, Jui‐Hung Sun, Alan G. Zimmermann, V. Pechtner	205
8	Safe and Effective Use of the Once Weekly Dulaglutide Single-Dose Pen in Injection-Naïve Patients With Type 2 Diabetes 2015 ·Journal of Diabetes Science and Technology ·Glenn Matfin, Kate Van Brunt, Alan G. Zimmermann, (unknown), (unknown)	43
9	Patient Experience With The Single-Use Pen For Injection of Once Weekly Dulaglutide in Injection-Naive Patients With Type 2 Diabetes 2014 ·Value in Health ·(unknown), (unknown), Alan G. Zimmermann, (unknown), Glenn Matfin	1
10	GH Treatment to Final Height Produces Similar Height Gains in Patients With SHOX Deficiency and Turner Syndrome: Results of a Multicenter Trial 2013 ·The Journal of Clinical Endocrinology & Metabolism ·Werner Blum, Judith L. Ross, Alan G. Zimmermann, Charmian A. Quigley, Christopher J. Child, G. Kalifa, Cheri Deal, Stenvert L. S. Drop, Gudrun Rappold, Gordon B. Cutler	66
11	Incidence of second neoplasm in childhood cancer survivors treated with GH: an analysis of GeNeSIS and HypoCCS 2013 ·European Journal of Endocrinology ·Whitney W. Woodmansee, Alan G. Zimmermann, Christopher J. Child, Rong Qi, Eva Marie Erfurth, Paolo Beck‐Peccoz, Werner Blum, Leslie L. Robison	47
12	Development of additional pituitary hormone deficiencies in pediatric patients originally diagnosed with idiopathic isolated GH deficiency 2013 ·European Journal of Endocrinology ·Werner Blum, Cheri Deal, Alan G. Zimmermann, Elena P. Shavrikova, Christopher J. Child, Charmian A. Quigley, Stenvert L. S. Drop, Gordon B. Cutler, Ron G. Rosenfeld	32
13	Associations between Pituitary Imaging Abnormalities and Clinical and Biochemical Phenotypes in Children with Congenital Growth Hormone Deficiency: Data from an International Observational Study 2013 ·Hormone Research in Paediatrics ·Cheri Deal, (unknown), Roland Pfäffle, Alan G. Zimmermann, Charmian A. Quigley, Christopher J. Child, Elena P. Shavrikova, Gordon B. Cutler, Werner Blum	44
14	Prevalence and Incidence of Diabetes Mellitus in GH-Treated Children and Adolescents: Analysis from the GeNeSIS Observational Research Program 2011 ·The Journal of Clinical Endocrinology & Metabolism ·Christopher J. Child, Alan G. Zimmermann, (unknown), Gordon B. Cutler, Tadej Battelino, Werner Blum	59
15	Metabolic, Cardiovascular, and Cerebrovascular Outcomes in Growth Hormone-Deficient Subjects with Previous Cushing’s Disease or Non-Functioning Pituitary Adenoma 2009 ·The Journal of Clinical Endocrinology & Metabolism ·Susan M. Webb, Daojun Mo, Steven W. J. Lamberts, Шломо Мелмед, Francesco Cavagnini, Francesca Pecori Giraldi, Christian J. Strasburger, Alan G. Zimmermann, Whitney W. Woodmansee, (unknown)	51
16	Randomized, controlled clinical trial of the efficacy of fluoxetine for treatment of compulsive disorders in dogs 2009 ·Journal of the American Veterinary Medical Association ·(unknown), Andrew U. Luescher, (unknown), Carol Robertson-Plouch, Alan G. Zimmermann, Rebecca R. Hozak	40
17	Prevalence of Metabolic Syndrome in Adult Hypopituitary Growth Hormone (GH)-Deficient Patients Before and After GH Replacement 2009 ·The Journal of Clinical Endocrinology & Metabolism ·Andrea Attanasio, Daojun Mo, Eva Marie Erfurth, Meng H. Tan, Ken Ho, David L. Kleinberg, Alan G. Zimmermann, Philippe Chanson	93
18	Preliminary studies on the effectiveness of the novel pulicide, spinosad, for the treatment and control of fleas on dogs 2007 ·Veterinary Parasitology ·Daniel E. Snyder, Jeffery A. Meyer, Alan G. Zimmermann, Meihua Qiao, (unknown), Larry R. Cruthers, (unknown), David R. Young	62
19	The epidemiology of neonatal tumours 2003 ·Pediatric Surgery International ·Simon W. Moore, (unknown), Annie J. Sasco, Alan G. Zimmermann, J. Plaschkes	102
20	Effects of tilmicosin on acute undifferentiated respiratory tract disease in newly arrived feedlot cattle 1998 ·Journal of the American Veterinary Medical Association ·G. J. Vogel, S.B. Laudert, Alan G. Zimmermann, (unknown), G.D. Mechor, (unknown)	37

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact